The menin small molecule inhibitors, such as MI-463, MI-503, MI-3454, and VTP-50469, markedly inhibit the proliferation and induce the differentiation of acute leukemia cells and primary patient samples with MLL translocations or NPM1 mutations. Here, KMT2A is linked to acute leukemia.